🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The polycystic ovary syndrome is the most common endocrinopathy in reproduc...
Status
Unknown
Location
Federal University of Sao Paulo
Start Date
2011-07
Trial ID
NCT00988078
This study will investigate the potential drug interactions between vemirco...
Status
Completed
Location
Research Site
Start Date
2024-01-17
Trial ID
NCT06071442
Treatments Being Tested
Oral contraceptives are known to improve menstrual cycles and symptoms in P...
Status
Completed
Location
University of Rochester Medical Center
Start Date
2006-01
Trial ID
NCT00283816
The purpose of this study to assess early markers of cardiovascular disease...
Status
Completed
Location
University of Sao Paulo
Start Date
2006-02
Trial ID
NCT00842140
Treatments Being Tested
The aim of the present study is to investigate a) the presence of subclinic...
Status
Recruiting
Location
Attikon University General Hospital
Start Date
2024-02-01
Trial ID
NCT06889454
Treatments Being Tested
The goal of this study is to determine the relative desirability of metform...
Status
Withdrawn
Location
University of Virginia
Start Date
2021-08-23
Trial ID
NCT03905941
Treatments Being Tested
Cardiovascular risk factors cluster in hyperandrogenic women - including th...
Status
Completed
Location
Department of Endocrinology, Hospital Ramón y Cajal
Start Date
2004-04
Trial ID
NCT00428311
Treatments Being Tested
The relationship between serum progesterone level on the day of human chori...
Status
Completed
Location
Women Health Hospital - Assiut university
Start Date
2017-03-01
Trial ID
NCT03088631
Polycystic ovary syndrome (PCOS) is a health problem that affects one in 10...
Status
Completed
Location
The Second Affiliated Hospital, Third Military Medical University
Start Date
2017-07-01
Trial ID
NCT03151005
Treatments Being Tested
The main aim of this study is to find out how zasocitinib (TAK-279) interac...
Status
Completed
Location
Celerion
Start Date
2025-01-23
Trial ID
NCT06793943
Treatments Being Tested